In order to study the molecular mechanisms of CD9's effects on bortezomib sensitivity in multiple myeloma, we did the genome-wide expression profile microarray to detect the differentially expressed genes and explore the molecular signaling pathways affected by CD9 expression. This evidence concerns the gene CD9 and plasma cell myeloma.